FRX News 92.59 05/16/2014 04:56:43 Forest Laboratories (FRX)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Forest Laboratories (FRX) 92.59 $FRX

SHAREHOLDER ALERT: Brower Piven Announces Class Action Lawsuit in Connection With the Sale of Furiex Pharmaceuticals, Inc. to Forest Laboratories, Inc. and Royal Empress, Inc. -- FURX
GlobeNewswire - Wed May 14, 6:10PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the Delaware Chancery Court on behalf of all common stockholders of Furiex Pharmaceuticals, Inc. ("Furiex" or the "Company" (Nasdaq:FURX) asserting claims that the members of the Company's board of directors have breached fiduciary duties they owe to Furiex shareholders.

Synergy Pharma Posts Narrower-than-Expected Q1 Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed May 14, 10:00AM CDT
Synergy Pharma (SGYP) reported first quarter 2014 loss of 18 cents per share, narrower than the Zacks Consensus Estimate of a loss of 24 cents.

Actavis Announces Proposed Senior Leadership Team Effective Following Completion of Forest Laboratories Acquisition
PR Newswire - Wed May 14, 7:00AM CDT
Actavis plc (NYSE: ACT) today announced the proposed senior management team that will lead the specialty pharmaceutical company pending the successful close of the acquisition of Forest Laboratories, Inc., which is anticipated at mid-year. Following the close, Paul Bisaro, Chairman and Chief Executive Officer of Actavis, will become Executive Chairman. Brent Saunders, currently CEO and President of Forest, will become CEO and President, and a member of the Board of Directors. Robert Stewart, President, Actavis Global Operations, will become Chief Operating Officer. Mr. Saunders will report to Mr. Bisaro and the Board of Directors, and Mr. Stewart will report to Mr. Saunders.

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of Furiex Pharmaceuticals, Inc. of Claims Against Board of Directors of Company In Connection With the Sale of the Company to Forest Laboratories, Inc. -- FURX
Business Wire - Tue May 13, 12:39PM CDT
Levi & Korsinsky notifies investors of Furiex Pharmaceuticals, Inc. ("Furiex" or "the Company" (NasdaqGS: FURX) of claims of breaches of fiduciary duty and other violations of state law against the board of directors of the Company in connection with the sale of the Company to Forest Laboratories, Inc. ("Forest" . A complaint was filed in Delaware state court.

INVESTOR ALERT: Levi & Korsinsky, LLP Announces Notifies Investors of Furiex Pharmaceuticals, Inc. of Claims Against Board of Directors of Company In Connection With the Sale of the Company to Forest Laboratories, Inc. -- FURX
Business Wire - Tue May 13, 12:34PM CDT
Levi & Korsinsky notifies investors of Furiex Pharmaceuticals, Inc. ("Furiex" or "the Company" (NasdaqGS: FURX) of claims of breaches of fiduciary duty and other violations of state law against the board of directors of the Company in connection with the sale of the Company to Forest Laboratories, Inc. ("Forest" . A complaint was filed in Delaware state court.

Prestigious Recognitions, Financial Results, Presentations, Study Analysis, and SEC Filings - Analyst Notes on WellPoint, NPS Pharma, Novartis, Cigna and Forest
PR Newswire - Tue May 13, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding WellPoint Inc. (NYSE: WLP), NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), Novartis AG (NYSE: NVS), Cigna Corp. (NYSE: CI) and Forest Laboratories Inc. (NYSE: FRX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/2384-100free.

RiverVest Venture Partners' Portfolio Company Lumena is Sold to Shire for $260 million; Represents Sixth Exit from RiverVest Venture Fund II
Business Wire - Mon May 12, 9:39AM CDT
RiverVest Venture Partners today announced portfolio company Lumena Pharmaceuticals has been sold to Dublin-based Shire Plc., in a transaction with an upfront payment of $260 million in cash, plus a payment for net cash at closing, and near-term contingent milestone payments related to ongoing clinical trials.

Pharma Stocks Technical Briefing -- Research on Forest Laboratories, Valeant Pharma, IntelliPharmaCeutics Intl., and Acura Pharma
PR Newswire - Thu May 08, 7:09AM CDT
On Wednesday, May 7, 2014, the NASDAQ Composite ended at 4,067.67, down 0.32%, the Dow Jones Industrial Average advanced 0.72%, to finish the day at 16,518.54, and the S&P 500 closed at 1,878.21, up 0.56%. During the session, eight out of ten sectors ended on a positive note. The S&P 500 Health Care Sector Index ended the day at 668.01, up 0.23%, with the index advancing 2.50% in the previous three months. Investor-Edge has initiated coverage on the following equities: Forest Laboratories Inc. (NYSE: FRX), Valeant Pharmaceuticals International Inc. (NYSE: VRX), IntelliPharmaCeutics International Inc. (NASDAQ: IPCI) and Acura Pharmaceuticals Inc (NASDAQ: ACUR). Free technical research on FRX, VRX, IPCI and ACUR can be downloaded upon signing up at:

SHAREHOLDER ALERT: Brower Piven Announces the Investigation of Furiex Pharmaceuticals, Inc. in Connection with the Proposed Sale of the Company to Forest Laboratories, Inc.
Business Wire - Mon May 05, 3:41PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty to current shareholders of Furiex Pharmaceuticals, Inc. ("Furiex" or the "Company" (NasdaqGS: FURX) and other violations of state law by the board of directors of Furiex relating to the proposed buyout of the Company by Forest Laboratories, Inc. ("Forest" .

Commit To Buy Forest Laboratories At $87.50, Earn 8.3% Annualized Using Options
at The Street - Mon May 05, 10:36AM CDT
Investors eyeing a purchase of Forest Laboratories, Inc. stock, but tentative about paying the going market price of $92.24/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Former Forest Laboratories GC Joins Lowenstein Sandler's Life Sciences Practice
PR Newswire - Mon May 05, 9:00AM CDT
Herschel S. Weinstein joined Lowenstein Sandler LLP today as Senior Counsel and Vice-Chair of its Life Sciences Group. Mr. Weinstein has more than 30 years of experience as in-house and outside counsel to the pharmaceutical industry. He most recently served as Senior Vice President and General Counsel at Forest Laboratories, the New York Stock Exchange listed specialty pharmaceutical company with more than $4 billion in annual revenue. Mr. Weinstein will be resident in Lowenstein's New York office.

Actavis and Forest Announce Effectiveness of Registration Statement on Form S-4
Business Wire - Mon May 05, 8:01AM CDT
Actavis plc (NYSE:ACT) and Forest Laboratories, Inc. (NYSE:FRX) today announced that the registration statement on Form S-4 filed with the U.S. Securities and Exchange Commission ("SEC" by Actavis plc on March 25, 2014 and amended on May 2, 2014 (the "Form S-4" , which includes a joint proxy statement of Actavis and Forest, was declared effective on May 2, 2014. The Form S-4 is available on the SEC's EDGAR system, and may be accessed at https://www.sec.gov/Archives/edgar/data/15788...59ds4a.htm.

Quarterly Earnings Releases, Social Initiatives, and Upcoming Conferences - Analyst Notes on Merck, WellPoint, UnitedHealth, Forest and Celgene
PR Newswire - Mon May 05, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Merck & Co. Inc. (NYSE: MRK), WellPoint Inc. (NYSE: WLP), UnitedHealth Group Inc. (NYSE: UNH), Forest Laboratories Inc. (NYSE: FRX) and Celgene Corporation (NASDAQ: CELG). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/2020-100free.

Forest Laboratories, Inc. to Present Data about Levomilnacipran and Vilazodone at the American Psychiatric Association 167th Annual Meeting
Business Wire - Fri May 02, 3:05PM CDT
Forest Laboratories, Inc. (NYSE:FRX) today announced it will be presenting data from its Major Depressive Disorder (MDD) portfolio, levomilnacipran and vilazodone, at the American Psychiatric Association (APA) 167th annual meeting (May 3-7, 2014 in New York, N.Y.).

INVESTOR ALERT - FURIEX PHARMACEUTICALS, INC.: The Law Offices of Vincent Wong Investigates the Sale of Furiex Pharmaceuticals, Inc.
Business Wire - Fri May 02, 10:21AM CDT
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Furiex Pharmaceuticals, Inc. (NasdaqGS:FURX) ("Furiex" in connection with the sale of the Company to Forest Laboratories, Inc. ("Forest" .

Health Care Stocks Still Healthy Despite Higher Hedging Costs
at The Street - Fri May 02, 5:30AM CDT
Health care is still outperforming the overall indices -- mergers and stellar sales figures and all. Can it be sustained?

A Look At World Stocks' Q1: Shire, Actavis, NXP Semi
at Investor's Business Daily - Thu May 01, 4:32PM CDT
Only a few IBD Top World Stocks have so far reported Q1 results. But the trend through Thursday has been very positive. Dublin, Ireland-based Shire (SHPG) retook a 172.37 buy point Thursday after reporting mixed first-quarter results. Earnings swung...

What's With All The Healthcare And Pharmaceutical Mergers?
at The Street - Thu May 01, 4:25PM CDT
James Dennin, Kapitall: Last Tuesday alone saw the announcement of $74 billion in potential healthcare and pharmaceutical mergers. In one day. [...]
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Unilumin's APEC 2026 Showcase Is a Useful Field Test

Updated Category News Views 41

Few sales pitches get stress-tested by a thousand journalists, a major airport, and a leaders' summit all at once. That is the useful part of Unilumin's role as an official sponsor of APEC 2026 in Shenzhen. The company says its LED systems were installed across summit venues, the media center, transportation hubs, and city landmarks as the 33rd APEC Economic Leaders'...

Continue Reading
Paratus on the Move: Seagems JV Under the Microscope

Updated Category News Views 131

What's Cooking with Paratus Energy? Paratus Energy Services Ltd. (ticker: PLSV) just threw us a curveball, announcing a strategic review of its participation in the Seagems joint venture. Now, before you get too jazzed about ticker talk—hold your horses. No one's making any promises about transactions just yet. The decision's still hanging in the balance, even as they...

Continue Reading
MAXHUB's Canon Office Test Puts Hybrid Work on Trial

Updated Category News Views 68

Thirty-nine devices scattered through a new Hong Kong office may not sound earth-shaking, but this is how workplace technology actually earns its keep: not under trade-show lights, but when somebody is late to a meeting in another time zone and the room has to work anyway. MAXHUB and Canon Hong Kong have launched the first officially delivered Co-Create 100 project...

Continue Reading
A Decade of Giving: Light the World Initiative's Impact

Updated Category News Views 118

The Red Kiosk Revolution It's not every day that a church initiative pops up in global conversations, but here we are—ten years into the Light the World initiative by The Church of Jesus Christ of Latter-day Saints. What's interesting is how these little kiosks, like silent ambassadors, have become a staple in 145 spots this holiday season, spanning continents. Each...

Continue Reading
FULC, DSGR and OPCH Deals Draw Fresh Shareholder Scrutiny

Updated Category News Views 64

Three proposed transactions have drawn the kind of legal glare that makes shareholders sit up and check the fine print twice. On November 18, 2026, Halper Sadeh LLC said it was investigating deals involving Fulcrum Therapeutics, Distribution Solutions Group, and Option Care Health for possible federal securities-law violations or fiduciary-duty breaches. That is not a...

Continue Reading
New Flight Charters Puts a Cap on Winter Surprises

Updated Category News Views 175

Ice on a wing is routine; ice on an invoice is where charter customers start muttering. New Flight Charters says it will again absorb de-icing and hangar charges this winter, up to $2,500 per trip, marking the seventh consecutive season for the program. In a business where the headline quote can look tidy and the final bill can arrive wearing muddy boots, that is a...

Continue Reading
Xailient Tops NIST for Real-World AI Face Recognition

Updated Category News Views 87

In a world where bigger ain't always better, Xailient's latest triumph at NIST's face recognition test has set them apart. On November 17, 2026, the U.S. National Institute of Standards and Technology (NIST) crowned Xailient as the leader in face recognition accuracy for on-device AI, leaving 105 others in the dust. This ain't your run-of-the-mill achievement—it shows...

Continue Reading
MetaComp Targets ASEAN's Cross-Border Payment Snarl

Updated Category News Views 30

ASEAN payment plumbing is still a patchwork, and MetaComp is betting that patchwork has finally become painful enough to fix. The Singapore-based payments firm says its StableX Agentic Network has topped 1,000 members and reaches more than 100,000 users in its first year. That is a respectable early footprint, not a victory lap. Cross-border payments are littered with...

Continue Reading
Cavalry’s I-70 Towing Bet Starts With Columbus Base

Updated Category News Views 71

A jackknifed tractor-trailer does not care about a private-equity playbook. It needs the right rig, a trained crew and somebody arriving before a blocked highway turns into an all-day mess. That unglamorous reality is exactly why Southfield Capital’s new Cavalry Fleet Services platform deserves a closer look. Commercial towing is a necessary, hard-edged local business...

Continue Reading
Mike Blyth’s Hall of Fame Honors a Builder’s Legacy

Updated Category News Views 147

Recognition earned in the hangar, not a boardroom Aircraft design has a ruthless way of exposing empty talk, which is why Mike Blyth’s November 11 induction into the EAA Homebuilders Hall of Fame carries real weight. The Experimental Aircraft Association’s honor, presented in the Eagle Hangar at the EAA Aviation Museum in Oshkosh, Wisconsin, recognizes a career built...

Continue Reading

Top 5 Most Recently Viewed Articles

Taiwan Semiconductor Rises as AI Demand Fuels Growth Potential

Updated Category News Views 226

Taiwan Semiconductor's Recent Performance Taiwan Semiconductor Manufacturing Company Ltd (NYSE: TSM) has witnessed impressive trading activity, nearing its 52-week high recently. The surge in stock price can be attributed to the increasing demand for AI technologies, which continues to invigorate the semiconductor industry. Analyst Insights on TSM Buy Rating and Price...

Continue Reading
TENX Plummets 85%: Shareholder Lawsuits Loom

Updated Category News Views 26

When Clinical Trials Go South When a Phase 3 trial misses its mark, you can bet the market's gonna react, and not in the way anyone holding shares of Tenax Therapeutics (NASDAQ:TENX) wanted. Last week, TENX lost a jaw-dropping 84-85% of its value in just one trading session. The culprit? The Phase 3 LEVEL trial of TNX-103 that failed to deliver—not hitting its primary...

Continue Reading
An Unforgettable Evening: Ismael Cala Foundation's Gala

Updated Category News Views 287

A Night of Elegance with the Ismael Cala Foundation A night of elegance, music, and Cuban culture to promote El Vuelo de la Cometa (The Flight of the Kite) An Enchanting Experience in a Tropical Paradise This year, the Ismael Cala Foundation is set to host its remarkable Legacy of Light Gala at the breathtaking Cala Botanic Sanctuary. Under the serene glow of the Full...

Continue Reading
FDCTech, Inc. Pursues Strategic Acquisition of Xoala in Europe

Updated Category News Views 171

FDCTech, Inc. Sets Course for European Market Expansion FDCTech, Inc. is taking a bold step into the European payments sector with the planned acquisition of Xoala, a regulated electronic money institution. This acquisition could reshape FDCTech's operational landscape, paving the way for growth in a market valued at approximately $2 trillion. Strategic Significance of...

Continue Reading
Heineken N.V. Updates on Its Share Buyback Program's Progress

Updated Category News Views 154

Heineken N.V. Provides Insights on Share Buyback Program Heineken N.V. is currently engaging in a share buyback program that reflects its commitment to enhancing shareholder value. Recently, the company disclosed substantial updates regarding transactions executed under the initial tranche of this program. Heineken N.V. (EURONEXT: HEIA; OTCQX: HEINY) announced that it has...

Continue Reading